Skip to Main Content
TABLE 2

The Clinical Significance of Treatment Results Expressed as RRs for Decrease in BMI z Score Using the Cutoffs 0.25 and 0.5

GroupDecrease in BMI z Score ≥0.25, RR (95% CI)Decrease in BMI z Score ≥0.5, RR (95% CI)
3-mo follow-up   
 Booster 1.4 (1.2 to 1.5)** 1.5 (1.2 to 1.8)** 
 No Booster 1.2 (1.1 to 1.4)* 1.1 (0.9 to 1.4) 
6-mo follow-up   
 Booster 1.8 (1.4 to 2.4)** 2.2 (1.6 to 3.1)** 
 No Booster 1.5 (1.1 to 2.0)* 1.3 (0.8 to 2.0) 
12-mo follow-up   
 Booster 3.3 (2.0 to 5.6)** 4.8 (2.4 to 9.6)** 
 No Booster 2.3 (1.3 to 3.9)* 1.6 (0.6 to 4.0) 
GroupDecrease in BMI z Score ≥0.25, RR (95% CI)Decrease in BMI z Score ≥0.5, RR (95% CI)
3-mo follow-up   
 Booster 1.4 (1.2 to 1.5)** 1.5 (1.2 to 1.8)** 
 No Booster 1.2 (1.1 to 1.4)* 1.1 (0.9 to 1.4) 
6-mo follow-up   
 Booster 1.8 (1.4 to 2.4)** 2.2 (1.6 to 3.1)** 
 No Booster 1.5 (1.1 to 2.0)* 1.3 (0.8 to 2.0) 
12-mo follow-up   
 Booster 3.3 (2.0 to 5.6)** 4.8 (2.4 to 9.6)** 
 No Booster 2.3 (1.3 to 3.9)* 1.6 (0.6 to 4.0) 

ST was used as a reference in all calculations.

*

P < .01; ** P < .001.

Close Modal

or Create an Account

Close Modal
Close Modal